Excellent response to levetiracetam in epilepsy with Wolf-Hirschhorn syndrome

@article{Karalok2015ExcellentRT,
  title={Excellent response to levetiracetam in epilepsy with Wolf-Hirschhorn syndrome},
  author={Zeynep Selen Karalok and Ebru Petek Arhan and Kadri Murat Erdogan and Esra Gurkas},
  journal={Child's Nervous System},
  year={2015},
  volume={32},
  pages={9-11}
}
Dear Editor: Wolf-Hirschhorn syndrome (WHS) is a rare genetic disorder caused by subtelomeric deletion of a segment of the short arm (p) of chromosome 4. Epilepsy constitutes a major medical challenge especially during the first years of life and occurs in 50–100 % of patients with WHS The conventional antiepileptic drugs such as carbamazepine, phenobarbitale, and valproic acid have been tried and are rarely effective in these patients [1, 2]. Levetiracetam is a new line antiepileptic drug… CONTINUE READING
2 Extracted Citations
7 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-7 of 7 references

focus on levetiracetam

  • H Klitgaard, Pitkanen A Antiepileptogenesis, neuroprotection, disease modification in the treatment of epilepsy
  • Epileptic Disord 5:9–16 Childs Nerv Syst
  • 2016
1 Excerpt

Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis

  • N Nagarkat t i, LS Deshpande, RJ DeLorenzo
  • Expert Rev Neurother
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…